Research and Markets: Drug Device Combination Market to 2016 - Technological Convergence to Be the New Business Model for Growth & Profitability

Research and Markets (http://www.researchandmarkets.com/research/e6a2c4/drug_device_combin) has announced the addition of the "Drug Device Combination Market to 2016 - Technological Convergence to be the New Business Model for Growth and Profitability" report to their offering.

Drug Device Combination Market to 2016 - Technological Convergence to be the New Business Model for Growth and Profitability provides key data, information and analysis on the drug device combination market. The report provides market landscape, competitive landscape and market trends information on five drug device combination market categories Drug-Eluting Stents, Antimicrobial Catheters, Antibiotic-Loaded Bone Cements, Drug Eluting Beads (DEB) and Photodynamic Therapy The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and a detailed analysis of the pipeline products.

The report also reviews details about important merger and acquisition deals that have taken place in the drug device combination market during the past three years. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Market Forecasts

The Drug/Device CP market is valued at $8.4 billion in 2009 and it is expected to grow at a CAGR of 12.6% during the period 2007-2016. The US market for Drug/Device CP is the largest geographical market comprising nearly 47.6 % of the global markets. The drug-eluting stent market is the largest market within the Drug/Device CP market, making up nearly 57.1 % of the total market in 2009. However, the drug-eluting bead market is the fastest micro-market among the segments within the scope of this study with a CAGR of 59.1% during the period 2007-2016.

Superior Operational Efficiency of Drug/Device CP Compared to its Individual Components Drives Growth of this Market Exponentially

Improved clinical outcomes of Drug/Device combination products as compared to its individual components, namely the medical device or the drug, has resulted in high growth of this market, with the CAGR estimated to be in double digit figures. Therapeutic efficiency of the drug in a CP is enhanced as a result of the controlled drug delivery locally, thus, also avoiding systemic toxicity. The anti-infective properties of the antimicrobial or antibiotic coatings on catheters and bone cements respectively permit the device to perform its functions for a longer period of time. This improved efficiency of the CP also, thus, improves the functional life of the implanted or inserted device. These benefits have resulted in greater user acceptance worldwide, and hence, the global revenues from this macro-market within the healthcare industry are poised for sharp growth in the next seven years corresponding to the period of this study.

Scope:

• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Market size and company share data for the drug-device combination market categories Drug eluting stents, antimicrobial catheters, antibiotic-loaded bone cements, drug-eluting beads, photodynamic therapy
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
• Qualitative analysis of key market trends, market drivers, and restraints by each category within the drug-device combination market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

Reasons to buy:

• Develop business strategies by understanding the trends and developments that are driving the drug-device combination market globally.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market players with the most innovative pipeline.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What's the next being thing in the drug-device combination market landscape? Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global drug-device combination market and the factors shaping it.

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Overview

4 Drug/Device CP Market Characterization

5 Drug/Device CP Market: Segment Analysis And Forecasts

6 Drug/Device CP Market: Geographical Analysis and Forecasts

7 Drug/Device CP Market: Regulatory Issues

8 Drug/Device CP Market: Competitive Landscape

9 Drug/Device CP Market: Strategic Consolidation

10 Appendix

For more information visit http://www.researchandmarkets.com/research/e6a2c4/drug_device_combin